Transplant Surgeon and Director of Transplant Informatics
General Surgery
Dr. David S. Bruce, MD
|
|
Give Review
David Bruce practices General Surgery. He went to medical school at University of Michigan Medical School. He received 2 awards: "CMS Meaningful Use Stage 1 Certification" and "Fellow (FACS)". Doctor David S. Bruce, MD has written publications. He has 47 publications published with PubMed. The lastest publication is: 'Complications in 100 living-liver donors.' He accepts Medicare payments and is listed with Medicare.gov.
Publications
- Excellent liver retransplantation outcomes in hepatitis C-infected recipients.
- Prospective, randomized, multi-center trial of antibody induction therapy in simultaneous pancreas-kidney transplantation.
- Hand-assisted laparoscopic living-donor nephrectomy as an alternative to traditional laparoscopic living-donor nephrectomy.
- Multicenter survey of daclizumab induction in simultaneous kidney-pancreas transplant recipients.
- Are concerns over right laparoscopic donor nephrectomy unwarranted?
- Hand-assisted laparoscopic live-donor nephrectomy.
- Hepatic resection: effective treatment for primary and secondary tumors.
- Combined liver and kidney transplantation in children.
- Primary living-donor liver transplantation at the University of Chicago: technical aspects of the first 104 recipients.
- Complications in 100 living-liver donors.
- Imaging of pancreatic transplantation using portal venous and enteric exocrine drainage.
- Cyclosporine versus cyclosporine microemulsion in pediatric liver transplant recipients.
- Successful use of tacrolimus for initial rejection episodes after liver transplantation.
- Corticosteroid cessation 1 week following renal transplantation using tacrolimus/mycophenolate mofetil based immunosuppression.
- Reversal of delayed hyperacute renal allograft rejection with a tacrolimus-based therapeutic regimen.
- Tacrolimus therapy for refractory acute renal allograft rejection: a 4-year experience with an aggressive approach.
- Tacrolimus/mycophenolate provides superior immunosuppression relative to neoral/mycophenolate in synchronous pancreas-kidney transplantation.
- An analysis of hepatic retransplantation in children.
- Analysis of fracture prevalence in kidney-pancreas allograft recipients.
- Synchronous pancreas-kidney transplantation with portal venous and enteric exocrine drainage: outcome in 70 consecutive cases.
- Effects of tacrolimus, mycophenolate mofetil, and cyclosporine microemulsion on rejection incidence in synchronous pancreas-kidney transplantation.
- Incidence and outcome of infection by vancomycin-resistant Enterococcus following orthotopic liver transplantation.
- Reversal of accelerated renal allograft rejection with FK 506.
- Impact of a liberalized donor acceptance policy on liver transplantation.
- Retransplantation for failed hepatic allografts in children.
- Biliary complications in living donor liver transplantation.
- Tacrolimus treatment of steroid-resistant rejection provides economic advantages compared with OKT3 therapy.
- Tacrolimus therapy for refractory renal allograft rejection: experience with steroid withdrawal.
- Comparison of pancreas transplantation with portal venous and enteric exocrine drainage to the standard technique utilizing bladder drainage of exocrine secretions.
- Use of polytetrafluoroethylene patch for temporary wound closure after pediatric liver transplantation.
- Tacrolimus therapy for refractory acute renal allograft rejection: definition of the histologic response by protocol biopsies.
- Portal vein thrombosis and stenosis in pediatric liver transplantation.
- Long-term outcome of kidney-pancreas transplant recipients with good graft function at one year.
- Posttransplant lymphoproliferative disease in pediatric liver transplantation. Interplay between primary Epstein-Barr virus infection and immunosuppression.
- OKT3 escalating dose regimens provide effective therapy for renal allograft rejection.
- FK 506 therapy for refractory renal allograft rejection: lessons from liver transplantation.
- Outcome of monoclonal antibody induction and anti-rejection therapy in pancreas transplantation.
- Tacrolimus for primary treatment of steroid-resistant hepatic allograft rejection.
- Treatment of steroid-resistant rejection with tacrolimus prior to OKT3 in liver transplant recipients.
- Role of protocol biopsies in the treatment of refractory renal allograft rejection with FK 506.
- Pancreas transplantation with portal venous drainage and enteric exocrine drainage offers early advantages without compromising safety or allograft function.
- Late complications in kidney-pancreas transplant recipients.
- Liver transplantation at the University of Chicago.
- Activation of T cells in vivo using anti-CD3 and staphylococcal enterotoxins.
- In vivo T-cell activation by staphylococcal enterotoxin B prevents outgrowth of a malignant tumor.
- Impaired Expression of Type I and Type II Interferon Receptors in HCV-Associated Chronic Liver Disease and Liver Cirrhosis.
Schools
University Of Michigan Medical School
University Of Chicago Hospitals
Procedures Preformed
- Colectomy
- Embolectomy, Thrombectomy, or Vessel Exploration
- Gallbladder Removal (Cholecystectomy), Laparoscopic
- Gallbladder Removal (Cholecystectomy), Open
- View All
Doctors Specialties
- General Surgery
Accepted Insurances
Awards
- CMS Meaningful Use Stage 1 Certification
- Fellow (FACS)
Education
-
University of Chicago -
University of Michigan Medical School
Drug Facts
| NPI NUMBER | 1043213069 | |
| NPPES Provider LastName | BRUCE | |
| NPPES Provider FirstName | DAVID | |
| NPPES Provider ZIPCode | 70121 | |
| NPPES Provider State | LA | |
| Specialty Description | General Surgery | |
| Total Claim Count | 245.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1043213069 |
| Last Name Of The Provider | BRUCE |
| First Name Of The Provider | DAVID |
| View All |
Similar Doctors
|
Dr. Ronald L. Nichols, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Robert L. Hewitt, MD |
|
|
Dr. James E. Brown Sr., MD |
|
|
Dr. Erika B. Lindholm, MD |
|
|
Dr. Buck A. Scott, MD |
|
|
Dr. Marie E. Unruh, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Matthew D. Zelhart, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Alan L. Levin, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Melvil B. Myers Jr., MD |
|
|
Dr. Julius L. Levy Jr., MD
This Doctor is OpenDoctor Recommended.
|